ELITE LABS INC FDA Approval ANDA 077169

ANDA 077169

ELITE LABS INC

FDA Drug Application

Application #077169

Application Sponsors

ANDA 077169ELITE LABS INC

Marketing Status

Prescription001
Prescription002

Application Products

001CAPSULE;ORAL2.5MG0ISRADIPINEISRADIPINE
002CAPSULE;ORAL5MG0ISRADIPINEISRADIPINE

FDA Submissions

ORIG1AP2006-04-24

TE Codes

001PrescriptionAB
002PrescriptionAB

CDER Filings

ELITE LABS INC
cder:Array
(
    [0] => Array
        (
            [ApplNo] => 77169
            [companyName] => ELITE LABS INC
            [docInserts] => ["",""]
            [products] => [{"drugName":"ISRADIPINE","activeIngredients":"ISRADIPINE","strength":"2.5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"},{"drugName":"ISRADIPINE","activeIngredients":"ISRADIPINE","strength":"5MG","dosageForm":"CAPSULE;ORAL","marketingStatus":"Prescription","te":"","rld":"No","rs":"No"}]
            [labels] => 
            [originalApprovals] => [{"actionDate":"ISRADIPINE","submission":"ISRADIPINE","actionType":"2.5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"},{"actionDate":"ISRADIPINE","submission":"ISRADIPINE","actionType":"5MG","submissionClassification":"CAPSULE;ORAL","reviewPriority":"Prescription","inserts":"[]","notes":">No"}]
            [supplements] => 
            [actionDate] => 1969-12-31
        )

)

© 2024 FDA.report
This site is not affiliated with or endorsed by the FDA.